Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Positron Corporation

Market Cap 59.78M 52.13M 48.28M 45.19M 84.76M 5.64B 85.27M 573M 222M 2.78B 224M 220M 9.64B P/E 2024
-11x
P/E 2025 -4.87x
Enterprise Value 58.65M 51.14M 47.36M 44.33M 83.15M 5.53B 83.65M 562M 218M 2.72B 220M 215M 9.46B EV / Sales 2024
49.4x
EV / Sales 2025 116x
Free-Float
47.44%
Yield 2024 *
-
Yield 2025 -
1 day+3.44%
1 week+1.68%
Current month-3.19%
1 month-0.61%
3 months-7.66%
6 months+17.42%
Current year+8.98%
1 week 1.56
Extreme 1.56
1.94
1 month 1.56
Extreme 1.56
1.94
Current year 1.43
Extreme 1.43
2.74
1 year 1.27
Extreme 1.27
2.74
3 years 0.87
Extreme 0.87
2.94
5 years 0.07
Extreme 0.0682
2.94
10 years 0
Extreme 0
2.94
Manager TitleAgeSince
President 53 27/02/2018
Sales & Marketing - 24/06/2022
Corporate Officer/Principal 40 25/05/2018
Director TitleAgeSince
Chairman 53 -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+3.44%+1.68%+15.92%+4.41% 59.78M
-5.99%-9.24%-18.60%-25.42% 12.55B
-0.26%+7.72%+98.44%+22.31% 5.28B
-1.04%-3.45%-37.13%-65.32% 1.21B
+1.69%-0.95%-32.51%-43.66% 1.19B
+1.22%-1.50%+57.74%+82.18% 1.18B
-0.53%-3.60%-38.30% - 950M
-5.27%-1.71%+209.31%+185.79% 705M
+1.69%-8.07% - - 330M
-0.74%-0.55%-57.24%+200.00% 250M
Average -0.58%-1.45%+21.96%+45.04% 2.37B
Weighted average by Cap. -3.29%-3.81%+15.74%-2.44%

Financials

2024 2025
Net sales 588K 512K 474K 444K 833K 55.44M 838K 5.63M 2.18M 27.29M 2.21M 2.16M 94.74M 461K 402K 373K 349K 654K 43.54M 658K 4.42M 1.71M 21.43M 1.73M 1.7M 74.42M
Net income -2.38M -2.07M -1.92M -1.8M -3.37M -224M -3.39M -22.79M -8.83M -110M -8.93M -8.74M -384M -10.6M -9.25M -8.56M -8.02M -15.03M -1B -15.12M -102M -39.37M -492M -39.8M -38.95M -1.71B
Net Debt 1.42M 1.24M 1.15M 1.08M 2.02M 134M 2.03M 13.65M 5.29M 66.16M 5.35M 5.23M 230M -1.14M -991K -917K -859K -1.61M -107M -1.62M -10.88M -4.22M -52.77M -4.26M -4.17M -183M
Logo Positron Corporation
Positron Corporation is a medical technology company focused to advancing the Positron Emission Tomography (PET) imaging modality through the development, manufacturing, and commercialization of its PET and PET-CT (Positron Emission Tomography/Computed Tomography) imaging systems along with providing comprehensive clinical services to nuclear medicine healthcare providers across North America. The Company specializes in the field of cardiac PET imaging, the gold standard in cardiac diagnostics. The Company’s imaging portfolio includes dedicated PET and 3D PET-CT 64-Slice systems, both designed to expand access to advanced molecular imaging. Additionally, it is preparing to introduce its 4D PET-CT 64-Slice scanner in nuclear cardiology. Its products, Attrius PET and NeuSight PET-CT 64- Slice scanner, provide a molecular imaging solution, enabling healthcare providers with diagnostic accuracy for cardiac and oncologic applications.
Employees
10
Date Price Change Volume
18/06/26 1.820 $ +3.44% 36,469
17/06/26 1.759 $ +1.06% 5,674
16/06/26 1.741 $ -2.74% 37,775
15/06/26 1.790 $ 0.00% 5,193
12/06/26 1.790 $ -1.16% 2,626
  1. Stock Market
  2. Stocks
  3. POSC Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!